Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
75,607,738
-
Total 13F shares
-
75,052,336
-
Share change
-
+1,429,218
-
Total reported value
-
$3,527,065,482
-
Put/Call ratio
-
9%
-
Price per share
-
$46.99
-
Number of holders
-
221
-
Value change
-
+$108,735,088
-
Number of buys
-
133
-
Number of sells
-
199
Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q2 2025
As of 30 Jun 2025,
SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by
221 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,052,336 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GLAZER CAPITAL, LLC, FIL Ltd, STATE STREET CORP, TIG Advisors, LLC, GOLDMAN SACHS GROUP INC, Beryl Capital Management LLC, Magnetar Financial LLC, and First Trust Capital Management L.P..
This page lists
221
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.